Success Metrics

Clinical Success Rate
100.0%

Based on 15 completed trials

Completion Rate
100%(15/15)
Active Trials
0(0%)
Results Posted
67%(10 trials)

Phase Distribution

Ph phase_2
10
67%
Ph phase_1
5
33%

Phase Distribution

5

Early Stage

10

Mid Stage

0

Late Stage

Phase Distribution15 total trials
Phase 1Safety & dosage
5(33.3%)
Phase 2Efficacy & side effects
10(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

15 of 15 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

15

all time

Status Distribution
Completed(15)

Detailed Status

Completed15

Development Timeline

Analytics

Development Status

Total Trials
15
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 15 (33.3%)
Phase 210 (66.7%)

Trials by Status

completed15100%

Recent Activity

Clinical Trials (15)

Showing 15 of 15 trials
NCT03395184Phase 2

Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF-06700841 In Subjects With Moderate To Severe Crohn's Disease

Completed
NCT05076006Phase 2

Dual JAK1/TYK2 Inhibitor for Cicatricial Alopecia

Completed
NCT04260464Phase 1

Renal Impairment Study of PF-06700841

Completed
NCT04092452Phase 2

A Study to Evaluate the Safety and Efficacy of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa

Completed
NCT02958865Phase 2

Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis

Completed
NCT03850483Phase 2

Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In Psoriasis

Completed
NCT03715829Phase 2

A Phase 2b Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Active Non-segmental Vitiligo Subjects

Completed
NCT03963401Phase 2

A Study to Evaluate the Efficacy and Safety of PF-06700841 in Subjects With Active Psoriatic Arthritis

Completed
NCT03903822Phase 2

Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic Dermatitis

Completed
NCT04267250Phase 1

Effect Of Multiple Dose PF-06700841 On The Pharmacokinetics Of Single Dose Oral Contraceptive Steroids

Completed
NCT02974868Phase 2

Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata

Completed
NCT04090047Phase 1

A Study to Investigate the Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of PF-06700841 in Healthy Participants

Completed
NCT02969018Phase 2

Study To Evaluate Safety And Efficacy Of PF-06700841 In Subjects With Moderate To Severe Plaque Psoriasis

Completed
NCT03656952Phase 1

A Study to Evaluate the PF-06700841 Effect on QTc Interval in Healthy Volunteers

Completed
NCT03236493Phase 1

Safety and Pharmacokinetic Study of PF-06700841 in Japanese Healthy Volunteers

Completed

All 15 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
15